IP Library Granted Patent US 11,434,512
Granted Patent B2
US 11,434,512 · App. 16/234,315 · Granted Sep 6, 2022

Production of fatty acid esters

Inventors: Fernando Sanchez-Riera (South San Francisco, CA); Stephen Del Cardayre (South San Francisco, CA); Fernando Valle (South San Francisco, CA)
Assignee: Genomatica, Inc.
C12P7/649C12N9/0006C12N9/0008C12N9/52C12P7/065Y02E50/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,434,512
App. No.
16/234,315
Granted
Sep 6, 2022
Kind
B2
Abstract

Methods of producing fatty acid esters, such as fatty acid ethyl esters, from genetically engineered microorganisms are described.

Claims (19)

1. A method of producing a fatty acid methyl ester (“FAME”) and/or a fatty acid ethyl ester (“FAEE”), the method comprising:

culturing a recombinant microorganism comprising overexpression of

(1) an exogenous nucleic acid sequence encoding a thioesterase (EC 3.1.2.),

(2) an exogenous nucleic acid sequence encoding an acyl-CoA synthase (EC 6.2.1.3), and

(3) an exogenous nucleic acid sequence encoding a wax synthase (EC 2.3.1.75), in the absence of exogenous alcohol;

wherein the recombinant microorganism is genetically engineered to overexpress at least one gene selected from the group consisting of pdh, panK, aceEF, accABCD, fabH, fabD, fabG, acpP, fabF, and udhA, relative to a corresponding wild type microorganism; and

wherein the recombinant microorganism produces the FAME and/or the FAEE when cultured in the presence of a carbohydrate carbon source.

2. The method of claim 1 , wherein the recombinant microorganism is genetically engineered to have reduced expression of at least one gene selected from the group consisting of ackA, ackB, adhE, fabF, fabR, fadE, gpsA, ldhA, pflB, plsB, poxB, pta, and glutathione synthase, relative to a corresponding wild type microorganism.

3. The method of claim 1 , wherein the recombinant microorganism is genetically engineered to have reduced expression of fabR, relative to a corresponding wild type microorganism.

4. The method of claim 1 , further comprising the step of isolating the FAME and/or the FAEE.

5. The method of claim 1 , wherein the recombinant microorganism is further genetically engineered to produce ethanol.

6. The method of claim 1 , wherein the FAEE is produced at a yield of 5 or 10 grams per 100 grams of glucose.

7. The method of claim 1 , wherein the recombinant microorganism is selected from a recombinant Escherichia coli cell, a recombinant yeast cell, and a recombinant cyanobacterium cell.

8. A recombinant microorganism for producing a fatty acid methyl ester (“FAME”) and/or a fatty acid ethyl ester (“FAEE”), wherein the recombinant microorganism is genetically engineered to overexpress an exogenous nucleic acid sequence encoding a thioesterase (EC 3.1.2.), an exogenous nucleic acid sequence encoding an acyl-CoA synthase (EC 6.2.1.3), and an exogenous nucleic acid sequence encoding a wax synthase (EC 2.3.1.75);

wherein the recombinant microorganism is genetically engineered to overexpress at least one gene selected from the group consisting ofpdh, panK, aceEF, accABCD, fabH, fabD, fabG, acpP, fabF, and udhA, relative to a corresponding wild type microorganism;

and

wherein the recombinant microorganism produces the FAME and/or the FAEE when cultured in the presence of a carbohydrate carbon source and in the absence of exogenously provided alcohol.

9. The recombinant microorganism of claim 8 , wherein the recombinant microorganism is genetically engineered to have reduced expression of at least one gene selected from the group consisting of ackA, ackB, adhE, fabF, fabR, fadE, gpsA, ldhA, pflB, plsB, poxB, pta, and glutathione synthase, relative to a corresponding wild type microorganism.

10. The recombinant microorganism of claim 8 , wherein the recombinant microorganism is selected from a recombinant Escherichia coli cell, a recombinant yeast cell, and a recombinant cyanobacterium cell.

Assignments (4)
SECURITY INTEREST Recorded Jun 2, 2025
From: GENOMATICA, INC.
To: OXFORD FINANCE LLC
Reel/Frame 071471/0770 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2022
From: SANCHEZ-RIERA, FERNANDO; DEL CARDAYRE, STEPHEN; VALLE, FERNANDO
To: LS9, INC.
Reel/Frame 060092/0946 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2022
From: LS9, INC.
To: REG LIFE SCIENCES, LLC
Reel/Frame 060093/0374 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2019
From: REG LIFE SCIENCES, LLC
To: GENOMATICA, INC.
Reel/Frame 050695/0661 →
Continuity (8)
Continuation 12768419 · Apr 27, 2010
Continuation In Part 12278957
Provisional Application 61182564 · May 29, 2009
Provisional Application 61173016 · Apr 27, 2009
Provisional Application 60802016 · May 19, 2006
Provisional Application 60801995 · May 19, 2006
Provisional Application 60908547 · Mar 28, 2007
Related Publication 20200017890A1 · Jan 16, 2020